Seattle, Washington, United States SABEY appeared to be the Corporate Investor, which was created in 1971. The main office of represented Corporate Investor is situated in the Seattle. The venture was found in North America in United States.
The important activity for fund was in 2017. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Health Care. Among the most popular portfolio startups of the fund, we may highlight Indi Molecular. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 4 participants. Despite the SABEY, startups are often financed by InterWest Partners, Asset Management Ventures (AMV). The meaningful sponsors for the fund in investment in the same round are M Ventures, Legend Capital, Asset Management Ventures (AMV).
Related Funds
| Fund Name | Location |
| Acappella Partners | - |
| Allston Venture Fund | Allston, Massachusetts, United States |
| Alto Partners Multi-Family Office | Central Region, Singapore, Singapore |
| Danske Bank | Copenhagen, Denmark, Hovedstaden |
| Elige Capital | France, Ile-de-France, Paris |
| Gen-Probe | California, San Diego, United States |
| Guoyuan Capital | Anhui, China, Hefei |
| Impact Collective | - |
| ISME ACE - FinTech Accelerator | India, Maharashtra, Mumbai |
| Macate Group | California, San Jose, United States |
| Nanji Quan | China, Guangdong, Shenzhen |
| Paramount Capital | Memphis, Tennessee, United States |
| PCRS Capital Partners | California, Long Beach, United States |
| Polyvalor Inc | - |
| R.W. Pressprich & Co | New York, New York, United States |
| Shengshi Jinhao Investment Management | - |
| Shenzhen O-film Technology | China, Guangming, Hunan |
| Shenzhenshi Baohualun Shiye Youxian Gongsi | China, Guangdong, Shenzhen |
| Yiju Zichan | China, Shanghai |
| Zhongdian Health Industry Fund | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Indi Molecular | $11M | 29 Jun 2017 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Indi Molecular | $11M | 29 Jun 2017 | California, United States |
